Recombinant Human Antithrombin III: rhATIII

By Adis International Limited  

Drugs in R&D, Vol. 5, Iss. 2, 2004-01 ,pp. : 110-112

Adis International

Access to resources Recommend Favorite

Development of nanoparticle-bound arylsulfatase B for enzyme replacement therapy of mucopolysaccharidosis VI

By Mühlstein A.   Gelperina S.   Kreuter J.  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 68, Iss. 7, 2013-07 ,pp. : 549-554

Govi-Verlag

Access to resources Recommend Favorite

Recombinant Human Interferon- -1a (Rebif) vs Recombinant Interferon- -1b (Betaseron) in Healthy Volunteers: A Pharmacodynamic and Tolerability Study

By Buraglio M.  

Clinical Drug Investigation, Vol. 18, Iss. 1, 1999-07 ,pp. : 27-34

Adis International

Access to resources Recommend Favorite

The Evaluation of CYP2B6 Inhibition by Artemisinin Antimalarials in Recombinant Enzymes and Human Liver Microsomes

By  

Drug Metabolism Letters, Vol. 6, Iss. 4, 2012-12 ,pp. : 247-257

Bentham Science Publishers

Access to resources Recommend Favorite

Understanding the Metabolic Consequences of Human Arylsulfatase A Deficiency through a Computational Systems Biology Study

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 17, Iss. 1, 2017-02 ,pp. : 72-77

Bentham Science Publishers

Access to resources Recommend Favorite